Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.271
+0.111 (5.13%)
Apr 8, 2026, 12:32 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Developing and Commercializing Its Medical Diagnostic Products
81.00K77.00K306.00K268.00K82.00K
Developing and Commercializing Its Medical Diagnostic Products Growth
5.19%-74.84%14.18%226.83%228.00%
Total
81.00K77.00K306.00K268.00K82.00K
Total Growth
5.19%-74.84%14.18%226.83%228.00%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
81.00K77.00K306.00K268.00K82.00K
United States Growth
5.19%-74.84%14.18%226.83%228.00%
Total
81.00K77.00K306.00K268.00K82.00K
Total Growth
5.19%-74.84%14.18%226.83%228.00%
Source: S&P Global Market Intelligence.